{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:53:29Z","timestamp":1791118409668,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T00:00:00Z","timestamp":1124668800000},"content-version":"vor","delay-in-days":1025,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p>Natural killer (NK) cell neoplasms are rare diseases. Frequent abnormalities of the tumor suppressor genes <jats:italic>Rb, p53, p151NK4B, p161NK4A<\/jats:italic> and <jats:italic>p14ARF<\/jats:italic> have been reported. However, no oncogenes associated with tumorigenesis of NK cell neoplasms have been reported so far. We analyzed the status of oncogenes including <jats:italic>N\u2010ras, K\u2010ras, H\u2010ras, c\u2010myc, N\u2010myc<\/jats:italic> and <jats:italic>mdm2<\/jats:italic> by Southern blot, PCR\u2010SSCP, western blot analysis and immunohistochemical staining. We analyzed four cell lines derived from NK cell neoplasms and 31 clinical samples with five subclasses of NK cell neoplasms. We found no point mutations of the <jats:italic>ras<\/jats:italic> family genes. We detected no mutations in the <jats:italic>c\u2010myc<\/jats:italic> and <jats:italic>N\u2010myc<\/jats:italic> genes. No overexpression of c\u2010Myc protein was detected by western blot analysis. Although we found neither amplification nor rearrangement of the <jats:italic>mdm2<\/jats:italic> gene, we found high expression of MDM2 protein in some cases by western blot analysis. Immunohistochemical staining confirmed the overexpression of MDM2 protein. We found 14 cases with overexpression of MDM2 protein out of 15 cases (93%) with four subclasses of NK cell neoplasms except chronic NK lymphocytosis. Our previous and these results suggested that the expression level of MDM2 protein is independent of the status of the <jats:italic>p14ARF, p53, Rb<\/jats:italic> genes. MDM2 protein might independently contribute to car\u2010cinogenesis of NK cell neoplasms. Although the number of the cases we analyzed was not large, alterations of <jats:italic>ras<\/jats:italic> and <jats:italic>myc<\/jats:italic> family genes may rarely contribute to tumorigenesis in NK cell neoplasms. In contrast, overexpression of MDM2 might be associated with tumorigenesis of NK cell neoplasms, especially aggressive subclasses.<\/jats:p>","DOI":"10.1111\/j.1349-7006.2002.tb01234.x","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T10:32:54Z","timestamp":1124706774000},"page":"1270-1277","source":"Crossref","is-referenced-by-count":12,"title":["Molecular Analysis of Oncogenes, <i>ras<\/i> Family Genes (<i>N\u2010ras, K\u2010ras, H\u2010ras<\/i>), <i>myc<\/i> Family Genes (<i>c\u2010myc, N\u2010myc<\/i>) and <i>mdm2<\/i> in Natural Killer Cell Neoplasms"],"prefix":"10.1111","volume":"93","author":[{"given":"Kei\u2010ji","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Sakajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Oshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-5710(96)00450-1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2417"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199710000-00014"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199601000-00012"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02615.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2721.2721"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809050908"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05303.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO;2-0"},{"key":"e_1_2_1_13_2","first-page":"177","article-title":"Peripheral T\u2010cell and NK\u2010cell neoplasms: an integrated approach to diagnosis","volume":"12","author":"Chan J. K.","year":"1999","journal-title":"Mod. Pathol."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.00582.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2000.7625"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909050949"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3223139.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65454-5"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780055"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01059.x"},{"key":"e_1_2_1_21_2","first-page":"2345","article-title":"Specific c\u2010kit mutations in sionasal natural killer\/T\u2010cell lymphoma in China and Japan","volume":"60","author":"Hongyo T.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205571"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609093436"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V96.5.1655","article-title":"Targeting the Ras signaling pathway: a rational, mechanism\u2010based treatment for hematologic malignancies","volume":"96","author":"Reuter C. W.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202746"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/26.15.3453"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(99)00038-6"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1541::AID-CNCR15>3.0.CO;2-Y"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019606-199603000-00006"},{"key":"e_1_2_1_30_2","first-page":"406","article-title":"Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia","volume":"24","author":"Robertson M. J.","year":"1996","journal-title":"Exp. Hematol."},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01029.x"},{"key":"e_1_2_1_32_2","first-page":"652","article-title":"Characterization of a human cell line (NK\u201092) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong J. H.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1374"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/sj.leu.2401778","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia\u2010lymphoma","volume":"14","author":"Drexler H. G.","year":"2000","journal-title":"Leukemia"},{"key":"e_1_2_1_35_2","volume-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook J.","year":"2001"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0993-56"},{"key":"e_1_2_1_37_2","first-page":"3383","article-title":"Mutations in the coding region of c\u2010MYC in AIDS\u2010associated and other aggressive lymphomas","volume":"54","author":"Clark H. M.","year":"1994","journal-title":"Cancer Res."},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00123-9"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.3.841.841"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3367"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low grade lymphoma of B\u2010cell origin","volume":"84","author":"Watanabe T.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401619"}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2002.tb01234.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2002.tb01234.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:12:38Z","timestamp":1700302358000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2002.tb01234.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1111\/j.1349-7006.2002.tb01234.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01234.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}